**Molecular and Clinical Bioinformatics (MCBI)**, a bioinformatics company founded in 2003, operates primarily in the biopharma and pharmaceutical industries. The company recently secured a substantial ¥510.00M in a Corporate Round investment on 22 August 2017, with significant backing from Shimadzu and Taiyo Life Insurance. This funding injection came as a crucial support for MCBI's further growth and development.